Displaying 25 - 36 of 41
Metabolism, Alcohol & Toxicity
Looking ahead: how to identify high-risk patients

Looking ahead: how to identify high-risk patients

Webcasts
View
Metabolism, Alcohol & Toxicity
Navigating the NASH healthcare system: global insights and challenges (panel discussion and Q&A)

Navigating the NASH healthcare system: global insights and challenges (panel discussion and Q&A)

Webcasts
View
Metabolism, Alcohol & Toxicity
The NASH treatment pipeline: focus on anti-metabolic approaches

The NASH treatment pipeline: focus on anti-metabolic approaches

Webcasts
View
Metabolism, Alcohol & Toxicity
Non-Invasive Assessment of Liver Fibrosis in Chronic Liver Diseases

Non-Invasive Assessment of Liver Fibrosis in Chronic Liver Diseases

Webcasts
View
Metabolism, Alcohol & Toxicity
Q&A

Q&A

Webcasts
View
Metabolism, Alcohol & Toxicity
Introduction

Introduction

Webcasts
View
Viral Hepatitis
A new beginning in hepatitis delta

A new beginning in hepatitis delta

Webcasts
View
Viral Hepatitis
A new paradigm for patients with hepatitis delta

A new paradigm for patients with hepatitis delta

Webcasts
View
Viral Hepatitis
Re-writing the treatment of hepatitis delta (PART 2)

Re-writing the treatment of hepatitis delta (PART 2)

Webcasts
View
Viral Hepatitis
Re-writing the treatment of hepatitis delta (PART 1)

Re-writing the treatment of hepatitis delta (PART 1)

Webcasts
View
Viral Hepatitis
Entry inhibitors in HDV

Entry inhibitors in HDV

Webcasts
View
Viral Hepatitis
Hepatitis delta: where it all began

Hepatitis delta: where it all began

Webcasts
View
Displaying 25 - 36 of 41